Nasdaq-listed biotech company Cytek boosts Singapore facility with US$3 million investment

[SINGAPORE] Flow cytometry company Cytek Biosciences has invested US$3 million in its Singapore facility as it expands its manufacturing and regional operations, its CEO said on Monday (Mar 9).